Andrew Hack

Dr. Hack has been a member of the Dynavax board since August 2019. Dr. Hack is a Managing Director at Bain Capital Life Sciences, a private equity fund that invests in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics, and enabling life science technology companies globally. Dr. Hack served as Chief Financial Officer of Editas Medicine, Inc. (NASDAQ: EDIT), from July 2015 to March 2019. Prior to joining Editas, he was a portfolio manager at Millennium Management LLC, an institutional asset manager, where he ran a healthcare fund focused on biotechnology, pharmaceutical, and medical device companies. Before joining Millennium, Dr. Hack was a healthcare analyst at HealthCor Management, L.P., a registered investment advisor. Previously, he served as a healthcare analyst for hedge fund Carlyle-Blue Wave Partners and as principal of the MPM BioEquities Fund, a hedge fund that was affiliated with MPM Capital. Earlier in his career, Dr. Hack was Director of Life Sciences and co-founder of Reify Corporation, a life science tools and drug discovery company. Dr. Hack serves as a director of Allena Pharmaceuticals, Inc. and Mersana Therapeutics, Inc. He received his B.A. in biology with special honors from the University of Chicago, where he also received his M.D. and Ph.D.

Before joining Editas Medicine, Hack was a portfolio manager at Millennium Management from May 2011 to May 2015. Andrew managed a market-neutral, diversified healthcare portfolio focused on biotechnology, pharmaceuticals and medical devices stocks.

Hack began their career as an analyst at HealthCor Management in December 2008. Andrew then moved to Carlyle-Blue Wave Partners in March 2007, where they worked as an analyst for one year. In January 2004, they became a biotechnology analyst at Bank of America and Rodman & Renshaw.

Andrew Hack's educational career began with him obtaining an A.B. in Biology from the University of Chicago. Andrew then went on to obtain a Ph.D. in Molecular Genetics and Cell Biology from the same school. Finally, they completed their education by obtaining an M.D. from The University of Chicago Pritzker School of Medicine.